Join team Australia at WHX Dubai in the UAE from 25-28 January 2027 and connect with global and regional healthcare companies seeking new technologies and expertise to match their business needs.
The United Arab Emirates (UAE) has seen a rise in its global stature for its health sector advancements. UAE's healthcare market is expected to reach a value of 6 billion AUD by 2030, as there is a strong demand from both a growing population and a thriving medical tourism industry, further supported by world-class infrastructure and a focus on digital health innovation. Australian health companies should consider the UAE for business due to its rapidly growing market, supportive and business-friendly regulatory environment, and strategic global location. As a gateway to the wider Middle East and Africa (MEA), the UAE also serves as a strategic hub for companies looking to expand their regional footprint and access high-growth markets.
The Australia-UAE CEPA benefits health companies through tariff elimination on products like pharmaceuticals, streamlined supply chains, and reduced regulatory hurdles. It enhances market access for Australian companies to expand their presence in the UAE and the broader Middle East, using the UAE as a regional hub. The agreement also promotes regulatory harmonisation, greater business certainty, and increased cooperation in the services sector, supporting efficient trade and new opportunities for Australia - UAE collaboration.
Why you should participate
WHX Dubai (previously known as Arab Health) is the largest event for healthcare and trade professionals in the Middle East and Africa (MEA) region. The exhibition attracts over 150,000 attendees and 4,000 exhibitors. This is a global event attended by health sector businesses from around the world, including health authorities, hospital groups, health conglomerates, private medical clinics, pathology groups, medical device manufacturers, and distributors. We expect all the major regional stakeholders from the growth markets in the GCC, and large multinationals from European and South Asian nations to visit WHX.
Australian healthcare service providers, medical device and pharma manufacturers, and digital health companies will have the opportunity to raise their profile on an international platform, unlock new export markets, increase export sales, and build partnerships and connections.
Companies across the following segments are encouraged to apply:
- medical devices / medtech
- digital health
- biotechnology
- consumer health.
In 2027, Austrade in partnership with Complementary Medicines Australia (CMA) and the Medical Technology Association of Australia (MTAA) will be delivering the Team Australia pavilion, B2B and B2G programs, delivering outcomes for Australian exporters. The business program will entail tailored business meetings and market briefings in the lead up to, and during WHX Dubai 2027. Austrade will work with all the Australian state governments to support outstanding Australian health businesses in their export growth.
Please note that the expression of interest is NOT yet an official registration to join the delegation to WHX Dubai. Austrade will evaluate all expressions of interest submitted. We will reach out to you to confirm your eligibility, as well as provide information on the next steps for registration and confirmation of participation.
